15 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

000661

Changchun High-Tech Industry (Group)
CN¥108.44-4.0%-29.6%CN¥43.6bn/aPE11.8xE22.0%4.1%

600285

Henan Lingrui Pharmaceutical
CN¥20.82-0.9%22.0%CN¥11.7bCN¥30.05PE17.3xE16.1%3.8%

000513

Livzon Pharmaceutical Group
CN¥36.00-3.0%4.4%CN¥29.2bCN¥40.29PE16.2xE10.2%3.8%

600566

Hubei Jumpcan Pharmaceutical
CN¥28.80-3.1%-6.7%CN¥26.5bn/aPE9.5xE10.7%4.5%

002275

Guilin Sanjin Pharmaceutical
CN¥14.790.5%-7.6%CN¥8.7bn/aPE21.3xE13.7%4.1%

603367

Cisen Pharmaceutical
CN¥14.20-0.9%-1.2%CN¥6.4bn/aPE12.2xn/a3.1%

603456

New
Zhejiang Jiuzhou Pharmaceutical
CN¥14.71-2.9%-44.7%CN¥13.2bCN¥18.16PE19xE20.2%3.4%

000650

New
Renhe PharmacyLtd
CN¥5.85-0.7%-16.4%CN¥8.1bn/aPE18.3xn/a3.4%

300653

Yantai Zhenghai Biotechnology
CN¥21.56-1.5%-27.9%CN¥3.8bCN¥29.25PE22.9xE15.0%3.7%

688526

New
Wuhan Keqian BiologyLtd
CN¥13.98-2.9%-28.3%CN¥6.5bCN¥20.20PE21.7xE25.1%3.1%

000423

Dong-E-E-JiaoLtd
CN¥56.59-2.4%12.8%CN¥36.4bCN¥75.95PE23.9xE13.9%4.1%

000915

Shandong Wit Dyne HealthLtd
CN¥25.620.2%-23.0%CN¥6.0bn/aPE12.3xE16.5%3.9%

300841

Chengdu Kanghua Biological Products
CN¥55.94-2.5%-29.4%CN¥7.3bCN¥75.18PE13.3xE18.0%3.6%

600750

Jiang Zhong PharmaceuticalLtd
CN¥20.21-4.7%-2.3%CN¥12.6bCN¥28.00PE16.8xE13.1%5.9%

002728

Teyi Pharmaceutical GroupLtd
CN¥8.863.1%-43.5%CN¥4.4bn/aPE62.4xE47.2%4.0%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.